PBTZ169

DRUG2 trials

Sponsors

Nearmedic Plus LLC, Innovative Medicines for Tuberculosis

Conditions

TuberculosisTuberculosis, Pulmonary

Phase 1

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing

CompletedNCT03776500

Innovative Medicines for TuberculosisTuberculosis, Pulmonary

Start: 2019-02-21End: 2020-03-20Updated: 2020-10-22

Phase 2

Phase 2a Study of PBTZ169

TerminatedNCT03334734

Nearmedic Plus LLCTuberculosis

Start: 2016-12-16End: 2018-02-22Updated: 2020-03-09